Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-001782
Filing Date
2017-07-17
Accepted
2017-07-17 11:50:23
Documents
30
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-053117.htm 10-Q 338238
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31 9715
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31 9575
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32 4882
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32 4720
  Complete submission text file 0001683168-17-001782.txt   1027605

Data Files

Seq Description Document Type Size
6 XBRL cnbx-20170531.xml EX-101.INS 67473
7 XBRL cnbx-20170531.xsd EX-101.SCH 11070
8 XBRL cnbx-20170531_cal.xml EX-101.CAL 24945
9 XBRL cnbx-20170531_def.xml EX-101.DEF 19101
10 XBRL cnbx-20170531_lab.xml EX-101.LAB 94909
11 XBRL cnbx-20170531_pre.xml EX-101.PRE 68863
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 17967028
SIC: 2834 Pharmaceutical Preparations